Drugmaker Eli Lilly's revenue rises 7.5 percent
April 25, 2017 at 06:51 AM EDT
(Reuters) - Eli Lilly and Co reported a 7.5 percent rise in quarterly revenue as the drugmaker benefited from higher demand for its new products including diabetes treatment Trulicity and psoriasis drug Taltz.
